Activation of Dendritic Cells Isolated from the Blood of Patients with Prostate Cancer by Ex Vivo Fluid Shear Stress Stimulation

Author:

Dombroski Jenna A.1,Antunovic Monika2,Schaffer Kerry R.23,Hurley Paula J.23,King Michael R.1ORCID

Affiliation:

1. Department of Biomedical Engineering Vanderbilt University Nashville Tennessee

2. Department of Medicine Vanderbilt University Medical Center Nashville Tennessee

3. Vanderbilt‐Ingram Cancer Center Nashville Tennessee

Abstract

AbstractProstate cancer is one of the most common cancers among men in the United States and a leading cause of cancer‐related death in men. Treatment options for patients with advanced prostate cancer include hormone therapies, chemotherapies, radioligand therapies, and immunotherapies. Provenge (sipuleucel‐T) is an autologous cancer‐vaccine‐based immunotherapy approved for men with asymptomatic or minimally symptomatic metastatic castration‐resistant prostate cancer (mCRPC). Administration of sipuleucel‐T involves leukapheresis of patient blood to isolate antigen‐presenting cells (APCs), including dendritic cells (DCs), and subsequent incubation of isolated APCs with both an antigen, prostatic acid phosphatase (PAP), and granulocyte macrophage‐colony stimulating factor (GM‐CSF) before their infusion back into the patient. Although sipuleucel‐T has been shown to improve overall survival, other meaningful outcomes, such as prostate‐specific antigen (PSA) levels and radiographic response, are inconsistent. This lack of robust response may be due to limited ex vivo activation of DCs using current protocols. Earlier studies have shown that many cell types can be activated ex vivo by external forces such as fluid shear stress (FSS). We hypothesize that novel fluid shear stress technologies and methods can be used to improve ex vivo efficacy of prostate cancer DC activation in prostate cancer. Herein, we report a new protocol for activating DCs from patients with prostate cancer using ex vivo fluid shear stress. Ultimately, the goal of these studies is to improve DC activation to expand the efficacy of therapies such as sipuleucel‐T. © 2023 The Authors. Current Protocols published by Wiley Periodicals LLC.Basic Protocol 1: Sample collection and DC isolationBasic Protocol 2: Determination and application of fluid shear stressBasic Protocol 3: Flow cytometry analysis of DCs after FSS stimulation

Publisher

Wiley

Subject

Medical Laboratory Technology,Health Informatics,General Pharmacology, Toxicology and Pharmaceutics,General Immunology and Microbiology,General Biochemistry, Genetics and Molecular Biology,General Neuroscience

Reference41 articles.

1. NF-κB Plays a Major Role in the Maturation of Human Dendritic Cells Induced by NiSO4 but not by DNCB

2. Sipuleucel‐T (Provenge) injection: The first immunotherapy agent (vaccine) for hormone‐refractory prostate cancer;Anassi E.;P & T: A Peer‐Reviewed Journal for Formulary Management,2011

3. The Dendritic Cell Synapse: A Life Dedicated to T Cell Activation

4. Prostate Cancer: Current Treatment and Prevention Strategies

5. Fluid shear stress enhances dendritic cell activation

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3